Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

A widely prescribed medication for underactive thyroid, levothyroxine, is potentially associated with bone loss, according to a study set for presentation at the Radiological Society of North ...

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented ...

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasize the need to ...

New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old ...

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study ...

For Monday, Nov. 25, WGN’s Dina Bair has the latest on new medical information, including: The holidays may be time to talk ...